Advertisement

Journal of Neurology

, Volume 257, Issue 4, pp 638–645 | Cite as

Social and clinical determinants of quality of life in Parkinson’s disease in Austria: a cohort study

  • Yaroslav Winter
  • Sonja von Campenhausen
  • Julia Gasser
  • Klaus Seppi
  • Jens-P. Reese
  • Karl-P. Pfeiffer
  • Kai Bötzel
  • Wolfgang H. Oertel
  • Richard Dodel
  • Werner Poewe
Original Communication

Abstract

Parkinson’s disease (PD) is associated with a reduction of health-related quality of life (HrQoL). Demographic and clinical determinants of HrQoL in PD have been previously investigated, but less is known about its social determinants. Data on HrQoL in Austrian patients with PD are not available. The objective of this cross-sectional survey was to evaluate HrQoL of Austrian patients with PD and to provide a comprehensive analysis of its social and clinical determinants. Outpatients (n = 100) with idiopathic PD were recruited in the Department of Neurology of the University Innsbruck. Clinical status was estimated using the Unified Parkison’s Disease Rating Scale (UPDRS). HrQoL was evaluated using a generic instrument, the EuroQol (EQ5D and EQ-VAS). Independent determinants of HrQoL were assessed in multivariate regression analysis. The proportion of PD patients with moderate or severe problems in at least one dimension of the EQ5D was significantly higher than in the general population (90.1 vs. 35.1%, P < 0.001). The mean EQ-VAS score in PD was lower than in the general population (48.9 ± 19.6 vs. 77.0 ± 20.8, P < 0.001). Social support (number of household members) was identified as an independent social determinant of HrQoL. Demographic and clinical determinants were age, depression, UPDRS and motor fluctuations. The analysis of determinants of HrQoL showed that a greater attention should be paid to social support and home care. Our data on HrQoL in PD should be considered in the development of new health care programs.

Keywords

Parkinson’s disease Quality of life EQ-5D Austria 

Notes

Acknowledgments

This study was supported by a grant of the European Commission (QLRT-2001-000 20) and the German Ministry of Education and Research (Competence network Parkinson syndromes; Nr.: 01GI9901/1). The authors’ work was independent of the funder.

Conflict of interest statement

All authors declare that they have no conflict of interest.

References

  1. 1.
    Andlin-Sobocki P, Jonsson B, Wittchen HU, Olesen J (2005) Costs of disorders of the brain in Europe. Eur J Neurol 12(suppl 1):1–27CrossRefPubMedGoogle Scholar
  2. 2.
    Brazier J, Jones N, Kind P (1993) Testing the validity of the EuroQoL and comparing it with the SF-36 health survey questionnaire. Qual Life Res 2:169–180CrossRefPubMedGoogle Scholar
  3. 3.
    Carod-Artal FJ, Vargas AP, Martinez-Martin P (2007) Determinants of quality of life in Brazilian patients with Parkinson’s disease. Mov Disord 22:1408–1415CrossRefPubMedGoogle Scholar
  4. 4.
    Chapuis S, Ouchchane L, Metz O, Gerbaud L, Durif F (2005) Impact of the motor complications of Parkinson’s disease on the quality of life. Mov Disord 20:224–230CrossRefPubMedGoogle Scholar
  5. 5.
    Ebrahim S (1995) Clinical and public health perspectives and applications of health-related quality of life measurement. Soc Sci Med 41:1383–1394CrossRefPubMedGoogle Scholar
  6. 6.
    Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198CrossRefPubMedGoogle Scholar
  7. 7.
    Forsaa EB, Larsen JP, Wentzel-Larsen T, Herlofson K, Alves G (2008) Predictors and course of health-related quality of life in Parkinson’s disease. Mov Disord 23:1420–1427CrossRefPubMedGoogle Scholar
  8. 8.
    Gibb WRG (1988) Accuracy in the clinical diagnosis of parkinsonian syndromes. Postgrad Med J 64:345–512CrossRefPubMedGoogle Scholar
  9. 9.
    Gomez-Esteban JC, Zarranz JJ, Lezcano E, Tijero B, Luna A, Velasco F, Rouco I, Garamendi I (2007) Influence of motor symptoms upon the quality of life of patients with Parkinson’s disease. Eur Neurol 57:161–165CrossRefPubMedGoogle Scholar
  10. 10.
    Greiner W, Weijnen T, Nieuwenhuizen M, Oppe S, Badia X, Busschbach J, Buxton M, Dolan P, Kind P, Krabbe P, Ohinmaa A, Parkin D, Roset M, Sintonen H, Tsuchiya A, de Charro F (2003) A single European currency for EQ-5D health states. Results from a six-country study. Eur J Health Econ 4:222–231CrossRefPubMedGoogle Scholar
  11. 11.
    Harrell FE (2001) Regression modeling strategies. Springer, New YorkGoogle Scholar
  12. 12.
    Hobson P, Holden A, Meara J (1999) Measuring the impact of Parkinson’s disease with the Parkinson’s disease quality of life questionnaire. Age Ageing 28:341–346CrossRefPubMedGoogle Scholar
  13. 13.
    Karlsen KH, Larsen JP, Tandberg E, Maeland JG (1999) Influence of clinical and demographic variables on quality of life in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 66:431–435CrossRefPubMedGoogle Scholar
  14. 14.
    Klepac N, Pikija S, Kraljic T, Relja M, Trkulja V, Juren S, Pavlicek I, Babic T (2007) Association of rural life setting and poorer quality of life in Parkinson’s disease patients: a cross-sectional study in Croatia. Eur J Neurol 14:194–198CrossRefPubMedGoogle Scholar
  15. 15.
    Konig HH, Bernert S, Angermeyer MC, Matschinger H, Martinez M, Vilagut G, Haro JM, de Girolamo G, de Graaf R, Kovess V, Alonso J (2009) Comparison of population health status in six European countries: results of a representative survey using the EQ-5D questionnaire. Med Care 47:255–261CrossRefPubMedGoogle Scholar
  16. 16.
    Kuopio AM, Marttila RJ, Helenius H, Toivonen M, Rinne UK (2000) The quality of life in Parkinson’s disease. Mov Disord 15:216–223CrossRefPubMedGoogle Scholar
  17. 17.
    Lindgren P, von Campenhausen S, Spottke AE, Siebert U, Dodel R (2005) Cost of Parkinson’s disease in Europe. Eur J Neurol 12(suppl 1):68–73CrossRefPubMedGoogle Scholar
  18. 18.
    Marras C, McDermott M, Rochon P, Tanner C, Naglie G, Lang A, Patrkinson Study Group DATATOP Investigators (2008) Predictors of deterioration in health-related quality of life in Parkinson’s disease: results from the DATATOP trial. Mov Disord 23:653–659CrossRefPubMedGoogle Scholar
  19. 19.
    Martinez-Martin P, Gil-Nagel A, Gracia LM, Gomez JB, Martinez-Sarries J, Bermejo F (1994) Unified Parkinson’s disease rating scale characteristics and structure. The Cooperative Multicentric Group. Mov Disord 9:76–83CrossRefPubMedGoogle Scholar
  20. 20.
    Pechevis M, Clarke CE, Vieregge P, Khoshnood B, Deschaseaux-Voinet C, Berdeaux G, Ziegler M (2005) Effects of dyskinesias in Parkinson’s disease on quality of life and health-related costs: a prospective European study. Eur J Neurol 12:956–963CrossRefPubMedGoogle Scholar
  21. 21.
    Peto V, Jenkinson C, Fitzpatrick R, Greenhall R (1995) The development and validation of a short measure of functioning and well being for individuals with Parkinson’s disease. Qual Life Res 4:241–248CrossRefPubMedGoogle Scholar
  22. 22.
    Rahman S, Griffin HJ, Quinn NP, Jahanshahi M (2008) Quality of life in Parkinson’s disease: the relative importance of the symptoms. Mov Disord 23:1428–1434CrossRefPubMedGoogle Scholar
  23. 23.
    Reuther M, Spottke EA, Klotsche J, Riedel O, Peter H, Berger K, Athen O, Köhne-Volland R, Dodel RC (2007) Assessing health-related quality of life in patients with Parkinson’s disease in a prospective longitudinal study. Parkinsonism Relat Disord 13:108–114CrossRefPubMedGoogle Scholar
  24. 24.
    Sautter J, Wick R, Adlkofer F, Baker MG (2003) Research in the European Union. Lancet Neurol 2:702–706CrossRefPubMedGoogle Scholar
  25. 25.
    Scaravilli T, Gasparoli E, Rinaldi F, Polesello G, Bracco F (2003) Health-related quality of life and sleep disorders in Parkinson’s disease. Neurol Sci 24:209–210CrossRefPubMedGoogle Scholar
  26. 26.
    Schrag A, Jahanshahi M, Quinn N (2000) How does Parkinson’s disease affect quality of life? A comparison with quality of life in the general population. Mov Disord 15:1112–1118CrossRefPubMedGoogle Scholar
  27. 27.
    Schrag A, Jahanshahi M, Quinn N (2000) What contributes to quality of life in patients with Parkinson’s disease? J Neurol Neurosurg Psychiatry 69:308–312CrossRefPubMedGoogle Scholar
  28. 28.
    Schrag A, Selai C, Jahanshani M, Quinn N (2000) The EQ-5D—a generic quality of life measure—is a useful instrument to measure quality of life in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 69:67–73CrossRefPubMedGoogle Scholar
  29. 29.
    Statistik Austria Statistisches Jahrbuch (2009) http://www.statistik.at/web_de/services/stat_jahrbuch/index.html. Accessed 20 December 2008
  30. 30.
    Group TheEuroQol (1990) EuroQol—a new facility for the measurement of health-related quality of life. Health Policy 16:199–208CrossRefGoogle Scholar
  31. 31.
    The Global Parkinson’s Disease Survey (GPDS) Steering Committee (2002) Factors impacting on quality of life in Parkinson’s disease: results from an international survey. Mov Disord 17:60–67CrossRefGoogle Scholar
  32. 32.
    Visser M, van Rooden SM, Verbaan D, Marinus J, Stiggelbout AM, van Hilten JJ (2008) A comprehensive model of health-related quality of life in Parkinson’s disease. J Neurol 255:1580–1587CrossRefPubMedGoogle Scholar
  33. 33.
    Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483CrossRefPubMedGoogle Scholar
  34. 34.
    Welsh M, McDermott MP, Holloway RG, Plumb S, Pfeiffer R, Hubble J (2003) Development and testing of the Parkinson’s disease quality of life scale. Mov Disord 18:637–645CrossRefPubMedGoogle Scholar
  35. 35.
    Winter Y, von Campenhausen S, Brozova H, Skoupa J, Reese JP, Botzel K, Eggert K, Oertel WH, Dodel R, Ruzicka E (2009) Costs of illness of Parkinson’s disease in Eastern Europe: a Czech cohort study. Parkinsonism Relat Disord [Epub ahead of print]Google Scholar
  36. 36.
    Winter Y, von Campenhausen S, Popov G, Reese JP, Klotsche J, Botzel K, Gusev E, Oertel WH, Dodel R, Guekht A (2009) Costs of Illness in a Russian Cohort of Patients with Parkinson’s Disease. PharmacoEconomics 27:571–584CrossRefPubMedGoogle Scholar
  37. 37.
    World Health Organization (1993) The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. World Health Organization, GenevaGoogle Scholar
  38. 38.
    Zach M, Friedman A, Slawek J, Derejko M (2004) Quality of life in Polish patients with long-lasting Parkinson’s disease. Mov Disord 19:667–672CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Yaroslav Winter
    • 1
  • Sonja von Campenhausen
    • 2
  • Julia Gasser
    • 3
  • Klaus Seppi
    • 3
  • Jens-P. Reese
    • 1
  • Karl-P. Pfeiffer
    • 4
  • Kai Bötzel
    • 2
  • Wolfgang H. Oertel
    • 1
  • Richard Dodel
    • 1
  • Werner Poewe
    • 3
  1. 1.Department of NeurologyPhilipps-University MarburgMarburgGermany
  2. 2.Department of NeurologyLudwig-Maximilians-UniversityMunichGermany
  3. 3.Department of NeurologyInnsbruck Medical UniversityInnsbruckAustria
  4. 4.Department of Medical Statistics, Informatics and Health EconomicsInnsbruck Medical UniversityInnsbruckAustria

Personalised recommendations